Bank of New York Mellon’s Nobilis Health Corp. HLTH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
Sell
-161,086
Closed -$274K 4377
2017
Q1
$274K Buy
161,086
+4,672
+3% +$9.72K ﹤0.01% 3777
2016
Q4
$328K Buy
156,414
+42,834
+38% +$117K ﹤0.01% 3754
2016
Q3
$381K Buy
113,580
+2,132
+2% +$6.41K ﹤0.01% 3662
2016
Q2
$248K Buy
111,448
+45,088
+68% +$146K ﹤0.01% 3822
2016
Q1
$207K Buy
66,360
+2,314
+4% +$5.98K ﹤0.01% 3779
2015
Q4
$180K Sell
64,046
-52,897
-45% -$169K ﹤0.01% 3891
2015
Q3
$610K Buy
116,943
+28,632
+32% +$164K ﹤0.01% 3486
2015
Q2
$600K Buy
+88,311
New +$626K ﹤0.01% 3572

Other funds holding HLTH

Bank of New York Mellon's HLTH Position: Q2 2017 in Review

Bank of New York Mellon sold out of Nobilis Health Corp. (HLTH) in Q2 2017, closing a stake of 161,086 shares — an estimated $274K sold.

Bank of New York Mellon first reported a position in HLTH in Q2 2015 and held it in 8 quarters. The position peaked at $610K in Q3 2015. 49 funds tracked by Wall St. Rank hold HLTH as of Q2 2017.

  • Bank of New York Mellon reported no remaining Nobilis Health Corp. position as of Q2 2017 after selling out during the quarter.
  • Bank of New York Mellon sold 161,086 Nobilis Health Corp. shares in Q2 2017, an estimated $274K.
  • Bank of New York Mellon first reported a position in Nobilis Health Corp. in Q2 2015 and held it in 8 quarters.
  • Bank of New York Mellon's Nobilis Health Corp. position peaked at $610K in Q3 2015.
  • 49 funds tracked by Wall St. Rank held Nobilis Health Corp. as of Q2 2017.

Based on Bank of New York Mellon's 13F filing for Q2 2017, filed 3 Aug 2017.